For example, the vaccine ATRQβ-001, targeting the angiotensin II type 1 receptor (AT1R), showed high efficiency in resisting hypertension and preventing various cardiovascular diseases in animal models [68]. This evidence concerns the gene AGTR1 and hypertensive disorder.